2018. Safety of Certolizumab Pegol in Chronic Plaque Psoriasis: Cumulative Data Over 48 Weeks’ Exposure from Phase 3, Multicenter, Randomized, Placebo-Controlled Studies. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S16. DOI:https://doi.org/10.25251/skin.2.supp.16.